ImmunityBio, Inc.IBRXNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-256.03M
↓ 14% vs avg
Percentile
P33
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-225.38M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-256.03M | +25.6% |
| 2024 | $-344.18M | +5.0% |
| 2023 | $-362.25M | -3.1% |
| 2022 | $-351.30M | -6.4% |
| 2021 | $-330.28M | -49.5% |
| 2020 | $-220.88M | -230.1% |
| 2019 | $-66.91M | +32.0% |
| 2018 | $-98.39M | +0.7% |
| 2017 | $-99.12M | +20.4% |
| 2016 | $-124.50M | - |